Management of imatinib-related exacerbation of psoriasis in a patient with a gastrointestinal stromal tumour

Haiying Cheng, David E. Geist, May Piperdi, Renu Virk, Bilal Piperdi

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

A 62-year-old woman with a pre-existing psoriasis was treated with oral imatinib (400 mg/day) for a metastatic gastrointestinal stromal tumour. Within 4 weeks of starting therapy, she developed a guttate psoriasis flare. The eruption markedly improved within 2 weeks following cessation of imatinib. However, it recurred when imatinib was recommenced. She has been able to continue on imatinib (400 mg/day) with low-dose oral methotrexate (12.5 mg/week) controlling the psoriasis.

Original languageEnglish (US)
Pages (from-to)41-43
Number of pages3
JournalAustralasian Journal of Dermatology
Volume50
Issue number1
DOIs
StatePublished - Feb 1 2009
Externally publishedYes

Keywords

  • Methotrexate
  • Tyrosine kinase inhibitors

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Management of imatinib-related exacerbation of psoriasis in a patient with a gastrointestinal stromal tumour'. Together they form a unique fingerprint.

Cite this